Literature DB >> 21310617

Mechanisms of GII.4 norovirus evolution.

Rowena A Bull1, Peter A White.   

Abstract

Since the late 1990s norovirus (NoV) strains belonging to a single genotype (GII.4) have caused at least four global epidemics. To date, the higher epidemiological fitness of the GII.4 strains has been attributed to a faster rate of evolution within the virus capsid, resulting in the ability to escape herd immunity. Four key factors have been proposed to influence the rate of evolution in NoV. These include host receptor recognition, sequence space, duration of herd immunity, and replication kinetics. In this review we discuss recent advancements in our understanding of these four mechanisms in relation to GII.4 evolution.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Mesh：

Year:  2011        PMID： 21310617     DOI： 10.1016/j.tim.2011.01.002

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  73 in total

1.  Comparative genome analysis of a norovirus GII.4 strain GZ2013-L10 isolated from South China.

Authors:  Liang Xue; Weicheng Cai; Qingping Wu; Xiaoxia Kou; Jumei Zhang; Weipeng Guo
Journal:  Virus Genes       Date:  2016-01-04       Impact factor: 2.332

2.  Molecular epidemiology of oyster-related human noroviruses and their global genetic diversity and temporal-geographical distribution from 1983 to 2014.

Authors:  Yongxin Yu; Hui Cai; Linghao Hu; Rongwei Lei; Yingjie Pan; Shuling Yan; Yongjie Wang
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

3.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

4.  Norovirus RNA-dependent RNA polymerase is phosphorylated by an important survival kinase, Akt.

Authors:  John-Sebastian Eden; Laura J Sharpe; Peter A White; Andrew J Brown
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

5.  Genetic and Epidemiologic Trends of Norovirus Outbreaks in the United States from 2013 to 2016 Demonstrated Emergence of Novel GII.4 Recombinant Viruses.

Authors:  Jennifer L Cannon; Leslie Barclay; Nikail R Collins; Mary E Wikswo; Christina J Castro; Laura Cristal Magaña; Nicole Gregoricus; Rachel L Marine; Preeti Chhabra; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2017-05-10       Impact factor: 5.948

6.  Viral mutation rates: modelling the roles of within-host viral dynamics and the trade-off between replication fidelity and speed.

Authors:  Roland R Regoes; Steven Hamblin; Mark M Tanaka
Journal:  Proc Biol Sci       Date:  2012-11-07       Impact factor: 5.349

7.  Complete genome sequence of a novel bovine norovirus: evidence for slow genetic evolution in genogroup III genotype 2 noroviruses.

Authors:  A Mauroy; A Scipioni; E Mathijs; D Ziant; G Daube; E Thiry
Journal:  J Virol       Date:  2012-11       Impact factor: 5.103

8.  The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012.

Authors:  John-Sebastian Eden; Joanne Hewitt; Kun Lee Lim; Maciej F Boni; Juan Merif; Gail Greening; Rodney M Ratcliff; Edward C Holmes; Mark M Tanaka; William D Rawlinson; Peter A White
Journal:  Virology       Date:  2013-12-25       Impact factor: 3.616

9.  Wipes coated with a singlet-oxygen-producing photosensitizer are effective against human influenza virus but not against norovirus.

Authors:  Katharina Verhaelen; Martijn Bouwknegt; Saskia Rutjes; Ana Maria de Roda Husman; Erwin Duizer
Journal:  Appl Environ Microbiol       Date:  2014-05-09       Impact factor: 4.792

10.  Recombination within the pandemic norovirus GII.4 lineage.

Authors:  John-Sebastian Eden; Mark M Tanaka; Maciej F Boni; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.